GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Ramky Infrastructure Ltd
Ramky Infrastructure Board approves share sale in Visakha Pharmacity
M&A ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 28 Mar 2026, 06:32 PM IST  ·  BSE ID: 494010d3-9071-4d06-b30f-c415dc391034
View Original BSE Filing (PDF)
💡
In Simple Terms
Ramky Infrastructure's board approved selling its stake in Visakha Pharmacity to another construction company.
🤖 AI Summary
  • Board approved sale of RIL shares in Visakha Pharmacity Limited to Brij Gopal Construction Company Private Limited
  • Managing Director and CFO authorized to finalize and execute Share Purchase Agreement terms and conditions
  • Decision follows member approval via Postal Ballot dated 27.12.2023, results declared 28.01.2024
  • Board meeting held 28.03.2026 — requisite SEBI disclosure details to follow post-SPA signing
🔢 Key Numbers — exact figures from BSE filing, not rounded
Board approval date
28.03.2026
Postal Ballot approval date
27.12.2023
Postal Ballot results declared
28.01.2024
🏢 How This Affects the Company
📈
Business Impact
Divestment of holding in Visakha Pharmacity reduces RIL's direct participation in that entity. Impact on revenue contribution depends on shareholding size and earnings from VPCL — not disclosed in filing.
💰
Financial Impact
Share sale will generate cash proceeds whose amount is not yet specified. Balance sheet impact on investments and cash position will be material upon SPA completion and settlement.
⚠️
Risk Impact
Transfer of operational control of VPCL shareholding from RIL to BGCCPL eliminates ongoing governance and management exposure to that entity's performance and liabilities.
👥 What This Means For Shareholders
✅
Action Required
No action required at this stage. Monitor for subsequent Regulation 30/31A disclosure post-SPA execution.
👤
Who Is Affected
All equity shareholders of RIL. Shareholding value in VPCL will be transferred out. Cash proceeds will flow to company treasury, affecting capital allocation and balance sheet composition.
🔍
Management Signal
Strategic portfolio rationalization — divestment of non-core or underperforming asset aligns with shareholder mandate established in December 2023.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Share Purchase Agreement signing — expect Reg 30 disclosure with transaction value and shareholding percentage
Transaction completion and settlement — watch for Reg 31A(10) promoter/stakeholder classification update
Q4 FY26 financial results — check cash impact and capital allocation of sale proceeds
MEDIUM RISK Shareholding percentage and sale value undisclosed. Cash deployment post-sale and strategic rationale for divestment remain unconfirmed.
💡 Investor Takeaway
Board approved sale of RIL's Visakha Pharmacity shareholding to Brij Gopal Construction Company following shareholder approval from January 2024. Transaction value and shareholding size not disclosed. Material SEBI disclosures to follow post-SPA execution.
⚖️ Strengths & Concerns

✅ Positives

  • Transaction pre-approved by shareholders via Postal Ballot — Jan 2024, reducing approval friction and execution risk

⚠️ Concerns

  • Share sale price and transaction value not disclosed — investors cannot assess deal economics or fairness
  • RIL shareholding percentage in VPCL not disclosed — extent of divestment impact on financials remains opaque
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.